|
Market Closed -
Nasdaq
08:00:00 10/11/26 am AEDT
|
5-day change | 1st Jan Change | ||
| 3.150 USD | +12.90% |
|
+3.28% | -72.96% |
| 07/11 | ARS Pharmaceuticals, Inc., Q3 2026 Earnings Call, Nov 05, 2026 | |
| 06/11 | Raymond James Downgrades ARS Pharmaceuticals to Outperform From Strong Buy, $17 Price Target | MT |
| Market Cap | 317M 283M 260M 236M 447M 29.68B 458M 3.11B 1.24B 15.89B 1.19B 1.16B 50.05B | P/E 2026 * |
-1.7x | P/E 2027 * | -3.93x |
|---|---|---|---|---|---|
| Enterprise Value | 317M 283M 260M 236M 447M 29.68B 458M 3.11B 1.24B 15.89B 1.19B 1.16B 50.05B | EV / Sales 2026 * |
2.61x | EV / Sales 2027 * | 1.86x |
| Free-Float |
83.82% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| SPRY | Delayed | |
CBOE
| SPRY | Real-time |
Last Transcript: ARS Pharmaceuticals, Inc.
| 1 day | +12.90% | ||
| 1 week | +3.28% | ||
| Current month | -6.80% | ||
| 1 month | -25.53% | ||
| 3 months | -48.86% | ||
| 6 months | -63.96% | ||
| Current year | -72.96% |
| 1 week | 2.44 |  | 3.22 |
| 1 month | 2.44 | | 4.44 |
| Current year | 2.44 | | 13.15 |
| 1 year | 2.44 | | 13.15 |
| 3 years | 2.44 | | 18.9 |
| 5 years | 2.44 | | 18.9 |
| 10 years | 2.44 | | 18.9 |
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Bell
CTO | Chief Tech/Sci/R&D Officer | - | 05/08/2015 |
Donn Casale
CEO | Chief Executive Officer | 53 | 07/07/2026 |
Kathleen Scott
DFI | Director of Finance/CFO | 57 | 01/02/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Pratik Shah
CHM | Chairman | 56 | 08/11/2022 |
Rajeev Dadoo
BRD | Director/Board Member | 55 | 01/08/2021 |
Saqib Islam
BRD | Director/Board Member | 56 | 01/07/2017 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 2/11/26 | Free | Chief Legal Officer | 1,199,482 | 1.2061% | ||
| 1/10/26 | Free | Chief Executive Officer | 1,036,923 | 1.0427% | ||
| 1/9/26 | Free | Executive/Senior Manager | 1,001,738 | 1.0073% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +12.90% | +3.28% | -64.41% | -8.16% | 280M | |
| +2.24% | +8.40% | +58.47% | +69.00% | 66.7B | |
| +4.66% | +8.90% | +16.93% | +85.41% | 56.88B | |
| -0.60% | +1.73% | +24.32% | +94.40% | 56.53B | |
| +2.55% | +15.52% | +30.43% | +120.17% | 46.49B | |
| +2.58% | +7.89% | +32.49% | +45.30% | 44.8B | |
| +4.09% | +6.37% | +228.06% | +899.75% | 41.59B | |
| -0.47% | +9.38% | +27.53% | +52.40% | 35.35B | |
| +3.80% | -1.00% | +98.16% | +66.79% | 33.29B | |
| +1.48% | +6.21% | -38.80% | +395.73% | 25.1B | |
| Average | +3.32% | +6.30% | +41.32% | +182.08% | 41B | |
| Weighted average by Cap. | +2.30% | +7.27% | +53.66% | +181.42% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 121M 108M 99.73M 90.51M 172M 11.38B 176M 1.19B 476M 6.09B 456M 446M 19.19B | 170M 152M 140M 127M 240M 15.94B 246M 1.67B 666M 8.54B 638M 625M 26.88B |
| Net income | -185M -165M -152M -138M -261M -17.34B -268M -1.82B -724M -9.28B -694M -679M -29.24B | -82.19M -73.36M -67.5M -61.27M -116M -7.7B -119M -808M -322M -4.12B -308M -302M -12.99B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 09/11/26 | USD 3.150 | +12.90% | 3,185,540 |
| 06/11/26 | USD 2.790 | +5.28% | 5,673,022 |
| 05/11/26 | USD 2.650 | -13.11% | 2,773,388 |
| 04/11/26 | USD 3.050 | 0.00% | 2,494,300 |
| 03/11/26 | USD 3.050 | 0.00% | 2,422,129 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- SPRY Stock
Select your edition
All financial news and data tailored to specific country editions
